Relapsing Multiple Sclerosis (RMS) Market Analysis

Multiple Sclerosis is an unpredictable, autoimmune disease that affects the central nervous system. In Multiple Sclerosis, the body’s immune system produces cells and proteins (antibodies) that attack the fatty substance, myelin, which is responsible for protecting the nerve fibres.

According to the revised McDonald Criteria, Multiple Sclerosis Relapse is defined as a “patient-reported or objectively observed event typical of an acute inflammatory demyelinating event in the central nervous system, current or historical, with the duration of at least 24 hours in the absence of fever or infection.”

Some of the key companies in the Relapsing Multiple Sclerosis market include Novartis, Teva Pharmaceuticals, Merck, TG Therapeutics, Sanofi and many others.

For more details on Relapsing Multiple Sclerosis (RMS) Market Insights, Epidemiology, and Pipeline Analysis, visit: https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market